Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association
-
To determine the effect of the preoperative duration of femoroacetabular impingement syndrome (FAIS)-associated symptoms on clinical outcomes at a minimum of 5 years after hip arthroscopy. ⋯ Level III, retrospective comparative trial.
-
Comparative Study
Revision Arthroscopic Posterior Shoulder Capsulolabral Repair in Contact Athletes: Risk Factors and Outcomes.
To determine risk factors and outcomes of revision arthroscopic posterior capsulolabral repair in contact athletes. ⋯ Level III, comparative study.
-
To (1) define Substantial Clinical Benefit (SCB), Patient Acceptable Symptomatic State (PASS), and Minimal Clinically Important Difference (MCID) for the visual analog scale (VAS) Satisfaction in patients undergoing hip arthroscopy for femoroacetabular impingement syndrome (FAIS), and (2) identify preoperative predictors of achieving each outcome end-point. ⋯ Level IV, Case Series.
-
To investigate the biomechanical effects of superior capsule reconstruction with subacromial allograft spacer on superior humeral head translation and subacromial contact pressure. ⋯ Superior capsule reconstruction with subacromial resurfacing using human dermal allograft reduces superior humeral head translation while increasing subacromial contact pressure in a cadaveric model.
-
To determine the effect prescription-limiting legislation passed in Rhode Island has had on opioids prescribed following arthroscopic knee and shoulder surgery at various time points, up to 90 days postoperatively. ⋯ Level III, case-control study.